cypep-1
Peptideexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 11, 2019 (NCT03846648)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05383170 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2023 | Cytovation AS, Merck |
| NCT04260529 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2020 | Cytovation AS, Erasmus University Rotterdam, Netherlands Cancer Institute |
| NCT03846648 | Phase 1 | Mar 11, 2019 | Leiden University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cytovation AS | For profit | 2 | 2 | 1 | 2020 |
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Merck | For profit | 1 | 0 | 1 | 2023 |
| Netherlands Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
5 organizations
Page 1 / 1